Prolonged intravenous eptifibatide infusion for prevention of coronary stent thrombosis

Area of Science:

• Cardiology
• Vascular Medicine
• Pharmacology

Background:

• Coronary bare-metal stent thrombosis is a critical complication following angioplasty, often leading to myocardial infarction and mortality.
• Standard prevention involves dual antiplatelet therapy with aspirin and clopidogrel.

Observation:

• A patient undergoing angioplasty required parenteral platelet inhibition due to inability to take oral medications post-gastrointestinal surgery.
• Intravenous eptifibatide was administered for 8 days to provide platelet inhibition.

Findings:

• This case demonstrates the feasibility of using intravenous eptifibatide for extended periods.
• Parenteral administration of glycoprotein IIb/IIIa inhibitors can achieve effective platelet inhibition.

Implications:

• Long-term intravenous glycoprotein IIb/IIIa inhibitors may offer a viable alternative for preventing stent thrombosis in select patient populations.
• This approach could be crucial for patients with contraindications to oral antiplatelet therapy, such as those with gastrointestinal issues.